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Workers in the petroleum industry are potentially exposed to a variety of petrochemicals,
including benzene or benzene-containing liquids. Although a large number of studies of petroleum
workers have been conducted to examine leukemia and other cancer risks, few existing studies
have investigated cell-type-specific leukemias. One of the major reasons for the lack of cell-type-
specific analysis was the small number of deaths by cell type in individual studies. In the present
investigation, all cohort studies of petroleum workers in the United States and the United
Kingdom were combined into a single database for cell-type-specific leukemia analysis. The majority
of these workers were petroleum refinery employees, but production, pipeline, and distribution
workers in the petroleum industry were also included. The combined cohort consisted of more
than 208,000 petroleum workers, who contributed more than 4.6 million person-years of
observation. Based on a meta-analysis of the combined data, cell-type-specific leukemia risks
were expressed in terms of standardized mortality ratios (meta-SMRs). The meta-SMR for acute
myeloid leukemia was 0.96. The lack of an increase of acute myeloid leukemia was attributed to
the low levels of benzene exposure in the petroleum industry, particularly in comparison to
benzene exposure levels in some previous studies of workers in other industries, who had been
found to experience an increased risk of acute myeloid leukemia. Similarly, no increase in chronic
myeloid, acute lymphocytic, or chronic lymphocytic leukemias was found in petroleum workers
(meta-SMRs of 0.89, 1.16, and 0.84, respectively). Stratified meta-analyses restricted to refinery
studies or to studies with at least 15 years of follow-up yielded similar results. The findings of the
present investigation are consistent with those from several recent case-control studies of cell-
type-specific leukemia. Patterns and levels of benzene exposure in the petroleum industry are
reviewed. The results of the present epidemiologic investigation are discussed in conjunction
with recent advances in leukemogenesis from other scientific disciplines. Environ Health
Perspect 104(Suppl 6):1381-1392 (1996)
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Introduction
Exposures to hydrocarbons in the petroleum
industry include inhalation ofvapors and
dermal contact of crude oil, feed stocks,
intermediate products during refining, and
end products, such as gasoline (1,2). Of
special concern is benzene, which has been
linked to an increased risk ofleukemia, par-
ticularly acute myeloid leukemia (AML).
Case reports suggesting an association
between exposure to benzene and leukemia
came primarily from England, Italy, France,
and Turkey (3-9). Documentation, if any
at all, ofexposures to benzene or benzene-
containing mixtures in these case reports
was extremely poor. Furthermore, these
reports lacked information concerning the
size of population at risk, and, therefore,
no risk estimates could be derived. Thus,
case reports by themselves do not provide
definitive evidence for causation, but rather
suggest potential areas for future epidemio-
logic research. One observation, however,
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emerged from these case reports: the
predominant cell type of the reported
leukemia cases was AML.
It was not until the 1970s that epidemi-
ologic studies of individuals exposed to
benzene were carried out. Judging by
today's standards, some ofthe early studies
were rather crude. For example, in the
Thorpe (10) study of leukemia incidence
among employees at eight Esso petroleum
affiliates in Europe, only active employees
and annuitants, but not separated employ-
ees, were included. Furthermore, person-
years of observation were estimated and
not actually calculated. Similarly, in the
Infante et al. (11) study of rubber hydro-
chloride workers exposed to benzene at two
Pliofilm manufacturing plants in Ohio,
the cohort was incomplete (an unknown
number ofemployment records were miss-
ing and no maintenance workers were
included). Furthermore, mortality ascertain-
ment in the Infante et al. (11) study was
only 75% complete. Likewise, employment
histories were also incomplete. It appeared
that some individuals included in the study
had worked at the facilities for only a few
days, and some might not have worked
there at all (12). Subsequent updates ofthe
Infante et al. (11) study by others (13,14)
have improved mortality ascertainment, but
the cohort incompleteness remained a
major limitation ofthe study.
In a 1983 report, Wong (15) discussed
some of the unresolved issues regarding
the relationship between benzene and
leukemia. The same issues were iterated by
a group of scientists convened by the
International Agency for Research on
Cancer (16). One of the major issues
raised by both Wong (15) and McMichael
(16) is the relationship, if any, between
benzene exposure and leukemia cell types
other than AML.
In the past, leukemia was considered
a single statistical category in most occu-
pational epidemiologic studies, partly
because of the historical nomenclature,
unavailability of cell-type-specific rates for
comparison, and, most importantly, the
paucity of cases by cell type in individual
studies (17,18). Recently, epidemiologic
studies have demonstrated the importance
of cell-type-specific analysis in studying
leukemia. It has now been recognized
that the diseases collectively known as
leukemia are several distinct malignancies
with different etiologic factors (19,20).
Similarly, the diversity ofdifferent types of
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leukemia has long been recognized by
hematologists (21).
The need to analyze leukemia data by
cell-type in relation to occupational expo-
sures such as benzene has created some
interesting challenges to epidemiologists.
Workers in the petroleum industry repre-
sent one ofthe largest populations exposed
to benzene. Numerous studies based on
petroleum workers have been conducted in
the United States and in the United
Kingdom. Even though most of these
studies consist of several thousand workers
who have been observed over several
decades, few individual studies offer ade-
quate data for cell-type-specific analysis.
The objective of the present investigation
was to combine all the studies ofpetroleum
workers in the United States and in the
United Kingdom into a single large data-
base, which can then be analyzed to evalu-
ate cell-type-specific leukemia risks in these
petroleum workers.
Methods and Materials
Based on a consideration of both study
design and data quality, only cohort studies
were included in the analysis. Studies based
on proportional mortality ratios (PMRs)
were excluded from analysis because ofthe
following limitations. In addition to the
well-known methodological deficiencies of
PMR studies (22,23), some of the PMR
studies ofpetroleum workers also suffered
from incomplete ascertainment ofdeaths
(24-27). Furthermore, employment his-
tories were not available in these PMR
studies, and analyses were limited. Finally,
the petroleum refineries included in these
PMR studies have subsequently been
studied more thoroughly with the cohort
study design.
In addition to cohort and PMRstudies,
there were also a number of community-
based case-control studies ofcell-type-spe-
cific leukemias, which included petroleum
or petroleum-related occupations in the
analyses. Most ofthese studies did not pro-
vide adequate information about the
nature of exposure or details ofemploy-
ment. Methodological problems (such as
control selection, recall ofemployment his-
tories, adjustment ofconfounding factors)
further complicated the interpretation.
Therefore, case-control studies were not
included in the quantitative analysis, but
formed part ofthe basis ofdiscussion.
A couple of reports based on linkage
between tumor registry and census data
have also been published (28,29). The
Olsen and Jensen (28) survey reported a
deficit ofacute leukemia in men employed
at gasoline stations in Denmark, whereas
the Jakobsson et al. (29) survey reported
an increased risk ofAML in petrol station
attendants in Finland. Both surveys were
judged to be inadequate. Using occupa-
tional information derived from census
data as a surrogate for exposure to specific
chemicals can introduce substantial mis-
classification. Moreover, estimating person-
years at risk or expected leukemia cases in
certain industries based on census data
involves a potentially substantial amount of
inaccuracy. The problem ofmultiple com-
parisons based on the large number of
cancer sites and industries or occupations
examined further weakens the statistical
findings from these surveys. As such, these
reports are inadequate in assessing leukemia
risk due to exposure to specific chemicals.
In the present investigation, a meta-
analysis procedure was used in combining
data from individual cohort studies of
petroleum workers. The methodological
details of the meta-analysis have been
described elsewhere (30). Data needed to
carry out the meta-analysis included
observed leukemia deaths by cell type and
the distribution ofage-specific person-years
from each individual study. These data
were usually not presented in published
reports. Instead, such data were requested
from the original investigators. For some
studies, multiple reports on various por-
tions of the cohort and/or updates were
available. For the present analysis, data
for the entire cohort based on the latest
available update were used.
A specific analysis was carried out for
each ofthe four major leukemia cell types
[AML or chronic myeloid leukemia (CML),
and acute (ALL) or chronic lymphocytic
leukemia (CLL)]. The 8th Revision ofthe
International Classification ofDiseases was
used in classifying deaths. The codes for
AML, CML, ALL, and CLL are 205.0,
205.1, 204.0, and 204.1, respectively. For
comparison in the U.S. studies, age-specific
mortality rates for each of the four major
leukemia cell types were derived from data
provided by the National Center for Health
Statistics (31). Although, in general, the
accuracy ofdiagnosis ofleukemia cell types
based on death certificates was not as desir-
able as that based on pathological reports
(particularly in the 1940s or 1950s), no
potential bias was introduced in the present
investigation, since diagnostic information
in both petroleum workers and the compar-
ison group (general population) was based
on death certificates. Furthermore, the
majority ofleukemia deaths in petroleum
workers occurred in or after the 1960s.
For each U.S. cohort, expected deaths
by cell-type were calculated by applying
U.S. specific rates to person-years. For the
U.K. industry-wide studies, cell-type-
specific information has been published,
and such information was taken directly
from the publications (32-34). One
Canadian cohort study (35) and one
Australian prospective survey (36,37) were
not included in the analysis because cell-
type-specific leukemia rates for Canada or
Australiawere not available.
The statistical procedure for meta-
analysis consists ofsumming the observed
and expected deaths for a specific leukemia
cell type from individual studies and calcu-
lating the summary or meta-standardized
mortality ratio (SMR). This simple proce-
dure treats each individual cohort as a sepa-
rate meta-stratum in data summarization,
thus adjusting for individual studies while
preserving the original adjustment using
substrata specific to age, sex, race, and time
period. In the present investigation, both
cell-type-specific leukemia meta-SMRs and
their corresponding 95% confidence inter-
vals were calculated. Although other
statistical procedures for meta-analysis are
available, the meta-SMR procedure was
used in this investigation because ofits sim-
plicity in computation and interpretation,
its preservation ofthe adjustments in the
individual studies, and its resemblance to
the analyses in the original studies. Similar
procedures have been used previously in
analyzing data on asbestos and gastro-
intestinal cancer (38), artificial sweeteners
and bladder cancer (39), formaldehyde and
respiratory cancer (40), chemical dyes and
bladder cancer (41), and radiation and colon
cancer (42). In particular, this method was
discussed in the interpretation ofnegative
epidemiological evidence for carcinogenicity
by the International Agency for Research
on Cancer (43).
An additional benefit ofmeta-analysis
is that it takes into consideration the multi-
ple-comparison problem exhibited in the
individual cohort studies. As discussed
below, a total of 19 individual cohorts have
been included in the database, which
means there would be 76 (19x4) cell-type-
specific SMRs. Approximately four statisti-
cally significant SMRs can be expected to
occur simplybychance alone at the ax= 5%
significance level. By combining data from
these 19 cohorts, excesses or deficits due to
chance for a particular cell type are less
likely to occur. For further discussion on
Environmental Health Perspectives - Vol 104, Supplement 6 - December 1996 1 382CELL-TYPE LEUKEMIA IN PETROLEUM WORKERS EXPOSED TO BENZENE
the meta-analysis of cohort studies, see
Wong and Raabe (30,44).
Results
Included in the analysis were studies con-
ducted or sponsored by seven major petro-
leum companies in the United States. Most
ofthese studies consisted ofrefinery work-
ers (45-68), except one, which was based
on workers in the production and pipeline
division (69). A study sponsored by the
American Petroleum Institute that con-
sisted ofa cohort ofland-based petroleum
distribution workers and a cohort ofmarine
petroleum distribution workers was also
included (70,71). From the United
Kingdom, two cohort studies ofpetroleum
refinery and distribution workers sponsored
by the Institute of Petroleum were
included (32-34,72,73).
Previously, Wong and Raabe (30) pro-
vided a meta-analysis of leukemia (all cell
types combined) based on studies ofpetro-
leum workers available at the time. The
total leukemia meta-SMR was 1.12 (not
significant) based on 279 deaths. Ofthe 14
U.S. or U.K. studies reviewed byWong and
Raabe (30), 3 refineries (Beaumont, Deer
Park, and Woodriver) showed a significant
increase in total leukemia. Since the Wong
and Raabe (30) review, all but two studies
in the United States and in the United
Kingdom have been updated. In particular,
based on the updated data, the total
leukemia SMR for the Beaumont refinery
has been reduced from 1.73 (p<0.05) to
1.39 (p>0.05), for the Deer Park refinery
from 2.31 (p<0.05) to 0.96 (p>0.05),
and for the Woodriver refinery from 2.12
(p<0.05) to 1.23 (p>0.05). Thus, all
three significantly elevated leukemia SMRs
reported in the 1989 review are no longer
statistically significant. Furthermore, the
updated Amoco study of 10 U.S. refineries
showed a significantly low total leukemia
SMR of 0.39. Three new cohorts have
been included in the present investigation,
and the total leukemia SMRs for all three
cohorts were < 1.0 (62,70,71). The
updated total leukemia meta-SMR based
on all petroleum cohorts in the United
States and the United Kingdom has been
recalculated to be 1.02 (498 observed
deaths, 95% CI: 0.93-1.11).
Table 1 provides a basic description of
the individual U.S. and U.K. cohort
studies included in the present investiga-
tion. Although exposure patterns in each
cohort might differ, all workers were
potentially exposed to benzene-containing
petroleum liquids as well as other hydro-
carbons. It is quite likely that the within-
cohort exposure variation is comparable to,
if not greater than, the between-cohort
exposure variation.
In the present investigation, a total of
19 individual cohorts were included in the
meta-analyses. The combined cohort
consisted ofmore than 208,000 petroleum
workers, with approximately 150,000 from
the United States and 58,000 from the
United Kingdom. Over an observation
period of 53 years (1937-1989), these
workers contributed more than 4.6 million
person-years. More than 56 thousand
deaths were reported in these studies. In
particular, 498 deaths were ascribed to
leukemia. Based on information available,
327 (66%) leukemia deaths among the
petroleum workers were classifiable into
one of the four major cell types: AML,
CML, ALL, and CLL. Thus, 34% leuke-
mia deaths in petroleum workers belonged
to other or unspecified cell types. According
to data provided by the National Center
for Health Statistics (74), the correspond-
ing figure in the general population was
similar (32-34%).
The distributions of leukemia deaths
among the U.S. and the U.K. petroleum
workers by the four major cell-types were
similar (Table 2). The cell-type distribu-
tion for the U.S. and U.K. combined
cohort ofpetroleum workers was also simi-
lar to that in the general adult population
(age 15 or older), which was derived from
Selvin et al. (31). A formal goodness-of-fit
test between the U.S. and U.K. combined
cohort of petroleum workers and the
general population indicated that there was
no significant difference between the two
distributions (X2 =2.00, 3df, p=0.57).
Table 3 and Figure 1 present the results
ofAML analysis for individual cohorts as
well as for the combined cohorts. Because
Table 1. Description of epidemiologic study cohorts in the petroleum industry in the United States and the United Kingdom.
Number of Observation Person- Total
Organization Cohort location workers period years deaths References
Amoco 10 refineries in U.S. 10,763 1970-1986 125,241 1,405 Hornstra (45); Nelson (46)
Chevron El Segundo, CA, refinery 4,773 1950-1986 110,594 1,121 Dagg et al. (47); Wong et al. (48)
Richmond, CA, refinery 8,523 1950-1986 205,397 2,038
Chevron (Gulf) Port Arthur, TX, refinery 17,844 1937-1987 526,386 6,799 Satin et al. (49); Wen et al. (50)
Exxon Baton Rouge, LA, refinery 9,894 1970-1982 93,785 2,000 Shallenberger et al. (51); Hanis et al.
Baytown, TX, refinery 8,722 1970-1982 80,684 1,374 (52-54)
Bayway, NJ, refinery 6,860 1970-1982 59,257 1,826
Mobil Beaumont, TX, refinery 7,119 1945-1987 166,427 2,294 Raabe et al. (55); Milcarek et al. (56);
Paulsboro, NJ, refinery 4,855 1946-1987 120,718 1,681 Collingwood et al. (57); Morgan and
Torrance, CA, refinery 1,991 1959-1987 33,331 408 Wong, (58,59); Enterline et al. (60)
Shell 2 California refineries 4,585 1973-1989 57,657 1,051 Tsai et al. (62); Marsh et al. (61); Honda
Deer Park, TX, refinery 6,831 1948-1983 181,782 1,180 et al. (63); Wongsrichanalai et al. (64);
Woodriver, IL, refinery 9,796 1940-1989 300,991 3,627 McCraw et al. (65); Joyner(66)
Texaco 13 refineries in U.S. 19,077 1947-1977 358,318 4,024 Divine et al. (67); Divine and Barron (68,69)
Production and pipeline in U.S. 11,098 1946-1980 220,414 1,886
American Petroleum Land-based terminals in U.S. 9,026 1946-1989 239,125 2,066 Wong et al. (71); Wong and Trent (70)
Institute Marine vessels in U.S. 9,109 1946-1989 227,143 2,695
Institute of 8 refineries in U.K. 34,569 1951-1989 931,640 10,193 Rushton (32-34); Rushton and Alderson
Petroleum Distribution centers in U.K. 23,306 1951-1989 626,471 8,743 (72,73)
Total U.S. and U.K. petroleum workers 208,741 1937-1989 4,665,361 56,411
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Table2. Comparison of leukemia cell-type distrib
Cell type U.S. (%)
Acute myeloid leukemia 103 (46)
Chronic myeloid leukemia 43 (19)
Acute lymphocytic leukemia 25(11)
Chronic lymphocytic leukemia 55(24)
Total 226 (100)
"Goodness-of-fit test between the U.S. and U.K.
tion, x2=2.00, 3df, p=0.57.
Table 3. Meta-analysis of acute myeloid leuke
Kingdom, 1937 to 1989.
Country Cohort Observ
U.S. A
B
C
0
E
F
G
H II
J
K
L
M
N
0
P
U.S. combined cohort 1
U.K. R s
U.K. combined cohort
U.S-U..K. combined cohort
A-
B-
C-
D-
F.
G-
H-
K-
L-
u-
p-
Combined (U.S.)-
R-
S-
Combined (U.K.)-
Combined -
(U.S. and U.K.)
0.1
iution between petroleum workers and the general population.a of the logarithmic scale, for SMRs <0.1,
neither the point estimate nor the lower
No. of petroleum workers1%) General 9 confidence limit is presented in the U.K. (%( U.S.-U.K. (%( population, figure. The number of observed AML
45(45) 148(46) 43 deaths in each cohort ranged from 0 to 25.
19(19) 62(19) 19 No significantly elevated AML SMR was
28 28) 83(25) 28 detected for any cohort. For cohort D, no
101 (100) 327 (100) 100 AML deaths were observed, and, based on
3.37 expected, this deficit was almost sta-
combined cohort of petroleum workers and the general popula- tistically significant (SMR= 0, 95% CI:
0-1.09, p= 0.06). For the U.S. combined
mia in petroleum workers in the United States and the United cohort, 103 AML deaths were reported,
compared to 107.68 expected. The corre-
sponding AML meta-SMR for the U.S.
red deaths Expected deaths SMB 95%CI combined cohort was 0.96, with a 95% CI
3 4.87 0.62 0.13-1.81 of 0.78 to 1.16. The U.K. combined
6 4.48 1.34 0.49-2.92 cohort yielded similar results for AML
O 3037 o jg (meta-SMR= 0.95, 95% CI: 0.70-1.27).
4 4.45 0.90 0.24-2.30 For the U.S.-U.K. combined cohort, there
14 l290 1.43 0.39-368 were 148 observed AML deaths, which 14 10.90 1.28 0.70-2.15
7 6.91 -;--1. 0.41-2.08 were comparable to the 154.88 expected,
5 7.88 0.63 0.20-1.47 and the meta-SMR for AML was 0.96
6 3.56 1.89 0.62-3.68 (95% CI: 0.81-1.13).
4 3.65 n0.30-102.82 Results based on a similar analysis for
8 6.15 1.30 0.56-2.56 CML are shown in Table 4 and in Figure
o 1.23 0 Q-3. 2. In the United States, most cohorts con-
1 4123 0.24 0.01-1.34 tributed fewer than five CML deaths each, 12 12.11 -0M.9 0.51-1.273
13 8.81 1.48 0.79-2.53 and the highest number ofeight observed
03 107.68 0.96 0.701.16 CML deaths was reported in cohort P. No
25 20.60 . 121 0.7-1.7 significant CML SMR was found in any of
45 47.20 0.95 0.70-1.27 the individual cohorts. For the U.S. com-
48 154.88 09 -081-1.13 bined cohort, 43 observed deaths were
ascribed to CML, whereas 47.97 CML
deaths were expected. For the U.S. com-
t.4---.---1----... . bined cohort, the CML meta-SMR was
I Itt I I I I I I 0.90, and the 95% CI was 0.65 to 1.21.
....4 For the U.K. combined cohort, the meta-
t----- l I SMR for CML was 0.86 (19 observed ver-
I I I I I l l l ...sus 22.00 expected, 95% CI: 0.52 to 1.35). 4........... l IIIII For the U.S. and U.K. combined cohort, a
I I r-I total of 62 CML deaths were observed,
10t compared to 69.97 expected. The CML 4.1 14 4----- meta-SMR for all petroleum workers was
0.89 (95% CI: 0.68-1.15).
s I| W ALL accounted for only 10 to 11% of
I 4 1 l l + the fourmajor cell types combined in both
I the petroleum workers and in the general
._..________________.. . I. I I population (Table 2). The number ofALL
I I::
I I I I :: deaths in each individual study was
4..I I extremely small. No more than two ALL
., I I I I I deaths were reported in most cohorts, and
~. I I six cohorts reported no ALL deaths at all
>--- -----------| ll (Table 5, Figure 3). In cohort K, however,
I I IL.L 8 ALL deaths were observed, compared to
3.08 expected. The ALL SMR for cohort K
was 2.60 (95% CI: 1.12-5.11). No other 1 10 cohort reported a significant ALL SMR. In
ardized mortality ratio and 95% Cl the U.S. combined cohort, 25 ALL deaths
were reported, slightly higher than the
eum workers in the U.S. and the U.K., 1937-1989; 148 observed 20.26 expected. The ALL meta-SMR for
295% Cl: 0.81-1.13). the U.S. combined cohort Was 1.23, which
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Table 4. Meta-analysis of chr(
Kingdom, 1937 to 1989.
Country C
U.S.
U.S.cobine. .coho
.. of
U.K.
U.K. combined cohort
U.S.-U.K. combined cohort
c.
D-
P1 G -j.
H]
,l
K-
L-
N-
p.
Combined (U.S.)-
R-
S-
Combined(U.K.)-
Combined-_
(U.S. andU.K.)
0.1
onic myeloid leukemia in petroleum workers in the United States and the United mortality. In fact, cohort K reported a
significantly low CLL SMR of 0.30 (3
,ohort Observeddeaths Expected deaths SMR 95%CI observed versus 10.04 expected, 95% CI:
A 0 2.06 0 0-1.79 0.06-0.87). On the other hand, cohort C
B 2 2;85 ° 0 ° reported a significantly high CLL SMR of
C 3 1.97 1.52 0.31-4.44 2.59 (9 observed vs 3.48 expected, 95%
0 -2 1 l.55 --s1- o.1u9O- CI: 1.18-4.91). A total of 55 CLL deaths
E 1 1.98 0.51 0.01-2.84 were observed in the U.S. combined
F 0 1.25; 0 '0-2.93 cohort, almost significantly less than the
G 2 4.85 0.41 0.05-1.48 69.19 expected (meta-SMR=0.79, 95%
H 3 3:508
097 0.20-2.3 CI: 0.59-1.03). There were 28 observed 1 ~ ~4 3.52 1.14 0.31-2.92
160 B 0.0:-nA 4 CLL deaths in the U.K. combined cohort,
K 6 7.11 0.84 0.31-1.83 slightly less than the 29.70 expected (meta-
1 4 1.58 2.53 .8944 SMR= 0.94, 95% CI: 0.63-1.36). In the
M 3 2.74 1.09 0.22-3.18 U.S. and U.K. combined cohort, 83 CLL
N 2 10.53.6 D deaths were observed, whereas 98.89 were
0 1 1.92 0.52 0.01-2.90
P .4 1..48
... expected; and the CLL meta-SMR was
Q 1 3.95 0.25 0.01-1.39 ~~~~0.84 (95% CI: 0.67-1.04).
43 47.97 ;; 1 The above meta-analyses were based on
R 11 12.30 0.89 0.44-1.59 all 19 cohorts ofpetroleum workers; includ-
S 8 9.711 0.82- ---:oS-- -- 0.35-1.82 ing refinery, production and pipeline, and
19 22.00 0.86 0.52-1.35 distribution workers. If the meta-analyses
6.2. -:O.' : :.:1:.... 95 62 59.97 089 0.6...1.15 were restricted to the 15 refinery cohorts
(14 from the United States and 1 from the
United Kingdom), the cell-type-specific
-------- ...... 4---. . -------------------I leukemia results remained essentially
I unchanged. The meta-SMRs for petroleum
------I I I -- refinery workers in the United States and
-------- r-----r---i---1---t-- ------- ----------1--------------------in the United Kingdom were 0.93, 0.94,
I ii :1 I I 1.32, and0.87for AML, CML, ALL, and
........ ! ! ! ! ! ! I Il " | | | CLL, respectively (Table 7). None of the
.............. i I meta-SMRs for the U.S.-U.K. combined
........ ... cohort ofpetroleum refinery workers was
I1 I I 1 1 1 1 t 1l statistically significant. : : : tt:: :: Among the 19 cohorts included in the
..... .. .. analysis, length of follow-up ranged from
tL ., I 13 to 51 years. Aseparateanalysis was car-
.......L.....L.... .I..I. I., II ried out based on cohorts with at least 15
t I I I I Iii years of follow-up. Using this criterion,
T IT 7 77 I I three cohorts were excluded. The results of
I I I I> IIII this analysis based on cohorts with 15+
I I , I lI l I years offollow-up are presented in Table 8.
-I-.I. I I iT I I 1 1 The results for follow-up of 15+ years
i i.. ---r- -X--------------- I. . I I I ii...r r40 remained essentially the same. .................. I.
.4. 1I....I....
', 'T
lI
Standardized mortality ratio and 95% Cl
Figure 2. Chronic myeloid leukemia among petroleum workers in the U.S. and the
deaths, meta-standardized mortality ratio = 0.89(95% Cl: 0.68-1.15).
was not significant (95% CI: 0.79-1.81).
The ALL meta-SMR for the U.K. com-
bined cohort was slightly less (meta-
SMR= 0.99, 95% CI: 0.45-1.88). In the
overall combined cohort of both U.S. and
U.K. petroleum workers, the observed
number ofALL deaths was 34, whereas the
U.K., 1937-1989; 62 observed
expected number was 29.36; and the ALL
meta-SMR was 1.16 (95% CI: 0.81-1.61).
Table 6 and Figure 4 present the results
of the CLL analysis. In the United States,
most individual cohorts reported four or
fewer CLL deaths. Ofthe 17 U.S. cohorts,
13 reported a lower than expected CLL
Discussion
The combined database in the meta-analysis
represented one of the largest databases in
epidemiologic research. Even though most
of the individual cohorts were relatively
large, it is evident from Tables 3-6 that most
of the cell-type-specific leukemia SMRs
based on individual cohorts were unstable,
as most were based on small numbers of
deaths (particularly for ALL). One of the
major advantages of the meta-analyses
carried out in the present investigation is
the stability ofthe combined data.
With regard to cell-type-specific
leukemia analyses, the statistical power of
the individual cohorts was' limited. This
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was particularly true for the U.S. cohorts,
most ofwhich were individual company or
individual refinery studies. The two U.K.
studies were larger, because they were
industry-wide studies consisting ofworkers
from several companies. Based on the aver-
age of the 17 individual cohorts in the
United States, the minimum SMR detect-
able at a=0.05 and , = 0.20 in an individ-
ual cohort were 2.22, 3.02, 4.57, and 2.61
for AML, CML, ALL, and CLL, respec-
tively. All ofthese SMRs were higher than
2-fold. The inadequacy ofstatistical power
of individual studies was particularly
evident forALL.
Statistical power increased substantially
by combining the 17 U.S. cohorts. Table 9
presents the minimum detectable SMRs at
a =0.05 and i = 0.20 for each ofthe four
major cell types. For AML, the U.S.
combined cohort provides sufficient statis-
tical power (80% power at the 0.05 level)
to detect a risk ratio as small as 1.25, if
indeed there was an increased risk. Based on
the U.S. combined cohort, the minimum
detectable SMRs were 1.39 for CML and
1.32 for CLL, respectively. Even for ALL,
the least frequent cell type, the minimum
detectable SMR based on the U.S. com-
bined cohort was 1.63. All the minimum
detectable SMRs based on the U.S. com-
bined cohort were less than 2-fold. The
statistical power of the U.K. combined
cohort was somewhat lower (Table 9). In
the overall U.S. and U.K. combined cohort
of petroleum workers, the minimum
detectable SMRs were 1.21, 1.32, 1.51, and
1.26 for AML, CML, ALL, and CLL,
respectively. Thus, the absence of an
increased risk ofAML, CML, ALL, or CLL
in petroleum workers in the United States
or in the United Kingdom based on the
meta-analyses in the present investigation
could not be attributed to inadequate
statistical power.
One may question why an increased
risk ofAML was not observed in petro-
leum workers, who were certainly exposed
to some levels of benzene. The answer
probably lies in the threshold of benzene
exposure required to produce a significant
increase ofAML. To estimate the thresh-
old, the data from the study of Pliofilm
workers exposed to benzene (14) updated
through 1987 were analyzed specifically for
AML in a recent investigation (75). For
the Pliofilm cohort as a whole, 6 deaths
from AML were observed, compared to
1.19 expected (Table 10). The correspond-
ing AML SMR of 5.03 was statistically
significant. However, exposure-response
Table 5. Meta-analysis of acute lymphocytic leukemia in petroleum workers in the United States and the United
Kingdom 1937 to 1989.
Country Cohort Observed deaths Expected deaths SMR 95% Cl
U.S. A 0 0.84 0 0-4.39
...11.22.0.82.....-4.57
C 1 0.89 1.12 0.03-6.24
-- -.- . - -- ::;: :;-::)0-.. 27
E 1 0.83 1.20 0.03-6.68
G 3 2.02 1.49 0.31-4.36
",ss~~~~~~~~~~~~~~~~~~:R1.. H1 1.32 0~~~ ~ ~~~.7w 0.2-423
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0 2 0.82 2.45 0.30-8.84
Q 2 1.62 1.23 0.15-4.44
. W r t i' . . t ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~~ ~ ~ ~ ~~~~~~~~~~~~~~~~~~~. J '['; '
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Figure 3. Acute lymphocytic leukemia among petroleum workers in the U.S. and the U.K., 1937-1989; 34 observed
deaths, meta-standardized mortality ratio = 1.16(95% Cl: 0.81-1.61).
analysis indicated that no increase ofAML
was detected for cumulative exposure
below 200 ppm-years (SMR=0.91).
Furthermore, the exposure levels provided
by Rinsky et al. (14) were likely under-
estimated, and more realistic exposure
estimates have been developed by others
(76,77). Had the other exposure estimates
been used, the observed AML threshold
would have been much higher, most likely
in the range of370 to 530 ppm-years (75).
Emerging evidence in the biologic search
for a mechanism ofbenzene-induced AML
suggests that benzene and its metabolites
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Table 6. Meta-analysis of chronic lymphocytic leukemia in petroleu
Kingdom, 1937 to 1989.
Country Cohort Observed deaths E
U.S. A 2
..
Cg
.::
.. ... .' :'.. .':..: .:.:.S .....: :..
..
:. ,:: ':: .: :. '; :. ':..' :: : :"
E 2 *:...........::.....:.:...............
I 4
......... ....
K 3
........
.
1
..S 2
'.:. :. .t: .- R..:W':..'. :.... ...:........::.: ,:,
U.K. R 12
U.K. combined cohort 28
L-Se coho 83,'
*p<0.05.
l1
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I
IF
,I------I-----I---r- -I-
I..1116-----I........I---
im workers in the United States and the United Similarly, benzene exposure levels in
case reports ofAML in shoemakers from
Istanbul, Turkey, were extremely high. xpected deaths SMR 95% Cl
These shoemakers, who used solvents con-
2.97 0.67 0.08--2.42 taining up to 88% benzene, were exposed
3'
3.48 2.59* 1.18-4.91
In addition, some of these shoemakers
2.92 0.69 0.08-2.49 worked at their homes and were thus
D:.:.s a posed allday and all weeklong. 6.99 1.14 0.49--2.24 On the contrary, benzene exposure at
refineries weresubstantiallylowercompared 4.99 0.80 0.22 05
.V.F-1-1'1-111.
to levels at the Pliofilm plants or among
....... ....A 9
Istanbul shoemakers. Forexample, for gen- 10.04 0.30* 0.06-0.87
..Q
M
W. 7 eral plant operations at petroleum refiner-
........ ..... ....... ....
4.09 0.24 0.01-1-34 ies in the United States, the mean benzene
level of 14,824 sam ples from an industry- 1.91 0.52 0.01-2.90
.... wide survey was 0.22 ppm (1). Forgauging
.... content in the field (byproduction work- 5-B7 0.34 0.04-1.23
ers) or at refinery tank farms (by refinery
15.80 0.76 0.39-1.33 workers), 60% of the industrial hygiene ....
Off, 1. ffil':.;:::: 'a'91111, ples were < I ppm, 22% between 1 and ..... ':' :.::
29.70 0.94 0.63-1.36 5 ppm, 8% between 5 and 10 ppm, 7%
....... --tween 10 and 25 ppm, and only 2%
between 25 and 50 ppm. Similarly, based
on a comprehensive survey in the petro-
leum refining industry, Spears et al. (81)
I............. reported that most measurements based on
both 8-hr and 15-min time-weighted aver-
------------------
age benzene exposures were below I ppm.
For U.S. land-based gasoline distribu-
tion workers, the highest exposures were
received by drivers oftank trucks using the
A splash method for loading during 1950 to
1964 (82); and their full-shift exposure
level for total hydrocarbons was estimated
to be 220 ppm, which was equivalent to
approximately 3.5 ppm of benzene (83).
For U.S. marine distribution workers the
highest exposures occurred amongdeck
---------- personnel during loading with open-hatch
venting (82); and their full-shift exposure
level for total hydrocarbons was estimated
to be 250 ppm, orapproximately 4 ppm of
benzene. Because of the higher benzene
content in gasoline in the United Kingdom
(generally twice as much), benzene expo-
sures in U.K. distribution workers have
10 been and are higher than their U.S. coun-
ratio and 95% Cl
terpart (perhaps, by a 2-fold difference).
These exposure data indicated that petro-
kers in the U.S. and the U.K., 1937-1989; 83
leum workers, even including those who
0.67-1.04).
worked in the industry decades ago, would
not have accumulated sufficient benzene
exposure in excess of the estimated AML
creased risk ofAML in petroleum threshold derived from the Pliofilmstudy.
-rs could have been due to the sub- Distribution ofleukemia cases by cell
ally lower benzene exposures in the type in the petroleum workers was similar
leum industry than in the Pliofilm to that in the general adult population
which included workers exposed to (Table 2). In particular, of the four major
ne levels as high as several hundred cell types, AML accounted for 46% in the
per million. petroleum workers and 43% in thegeneral
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Figure 4. Chronic lymphocytic leukemia among petroleum work
observed deaths, meta-standardized mortality ratio = 0.84(95% Cl:
may induce AML via toxic disruption of
regulatory mechanisms ofcell growth and
differentiation (78). If benzene-induced
toxicity is a conditional step in benzene-
related AML, this would lend biologic
support to the observed threshold based on
epidemiologic data (79). Thus, the lack of
an in(
worke
stanti,,
petrol
study,
benzei
parts I
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Table 7. Meta-analysis of cell-type specific leukemias in refinery workers in the United States and the United
Kingdom, 1937 to 1989.
Cell type Observed deaths Expected deaths Meta-SMR 95% Cl
Acute myeloid leukemia 78 84.08 0.93 0.73-1.16
Chronic myeloid leukemia 35 37.42 0.94 0.65-1.31
Acute lymphocytic leukemia 21 15.85 1.32 0.81-2.01
Chronic lymphocytic leukemia 47 54.23 0.87 0.64-1.16
Table 8. Meta-analysis of cell-type-specific leukemias in petroleum workers in the United States and the United
Kingdom, 1937 to 1989, based on cohorts with 15 or more years offollow-up.
Cell type Observed deaths Expected deaths Meta-SMR 95% Cl
Acute myeloid leukemia 138 143.38 0.96 0.81-1.14
Chronic myeloid leukemia 53 64.86 0.82 0.62-1.08
Acute lymphocytic leukemia 33 27.08 1.22 0.83-1.71
Chronic lymphocytic leukemia 71 89.74 0.79 0.62-1.00
Table 9. Minimum detectable standard mortality ratios (at a=0.05 and P=0.20) by leukemia cell type in com-
bined cohorts of petroleum workers.
Combined Cell Observed Expected Meta- 95% Cl Minimum
cohort type deaths deaths SMR Lower limit Upper limit p-Value detectable SMR
U.S. AML 103 107.68 0.96 0.78 1.16 0.65 1.25
CML 43 47.97 0.90 0.65 1.21 0.47 1.39
ALL 25 20.26 1.23 0.79 1.81 0.29 1.63
CLL 55 69.19 0.79 0.59 1.03 0.08 1.32
U.K. AML 45 47.20 0.95 0.70 1.27 0.75 1.39
CML 19 22.00 0.86 0.52 1.35 0.51 1.60
ALL 9 9.10 0.99 0.45 1.88 0.97 1.99
CML 28 29.70 0.94 0.63 1.36 0.75 1.51
U.S. and U.K. AML 148 154.88 0.96 0.81 1.13 0.58 1.21
CML 62 69.97 0.89 0.68 1.15 0.34 1.32
ALL 34 29.36 1.16 0.81 1.61 0.40 1.51
CLL 83 98.89 0.84 0.67 1.04 0.10 1.26
Table 10. Acute myeloid leukemia bycumulative benzene exposure.
Cumulative exposure,
ppm-years Observed deaths Expected deaths SMR 95% Cl
<40 1 1 0.84 1.09 1.19 0.91 0.03-6.63 00251 40-200 0 0.25 0 0-14.75 002-5.11
200-400 2 0.07 27.21** 3.29-98.24
400+ 3 0.03 98.37** 20.28-287.65
Total 6 1.19 5.03** 1.84-10.97
**p< 0.01.
adult population. In contrast, 85% of the
leukemia patients with benzene exposure in
Istanbul (the majority being shoemakers)
had acute nonlymphocytic leukemia
(ANLL) (19,84).
Because of the generally low benzene
exposures among petroleum workers, the
lack ofan increased risk ofAML is not sur-
prising. Ofthe 19 individual cohorts exam-
ined, none showed a statistically significant
AML SMR. In a previous analysis based on
cohort G, AML was significantly elevated
(SMR=2.19, 95% CI: 1.13-3.82) (64). A
nested case-control study within cohort G
has been conducted to determine the cause
ofthe increase (85). The investigation did
not identify any specific job or department
responsible for the increase, and compari-
son of the benzene exposure levels of cases
and controls did not indicate any associa-
tion with benzene exposure at the refinery.
The authors offered several possible rea-
sons for the increase: a) unidentified expo-
sures other than benzene at the refinery,
b) exposures at work sites other than the
refinery, c) unidentified nonoccupational
exposures, or d) chance. Based on the pre-
sent meta-analysis, it was unlikely that
some yet unidentified exposures other than
benzene were responsible for the AML
increase reported in the previous analysis of
cohort G, unless these unidentified expo-
sures were unique to that particular
refinery. More likely, the AML increase in
cohort G was due to one or more of the
other three reasons offered by the investiga-
tors ofthe original study. For example, cig-
arette smoking and other nonoccupational
lifestyle risk factors have been linked to an
increased risk of AML in some recent
studies (19,86-88). In any event, the analy-
sis based on the latest update ofcohort G
indicated that AML was no longer
significantly elevated (SMR= 1.28, 95%
CI: 0.70-2.15).
For CML, no significant increase or
deficit was observed in the individual
cohorts ofpetroleum workers. The meta-
analyses based on the combined cohorts
showed that there was no increase ofCML.
This finding ofno increased CML risk was
further supported by two case-control
studies ofCML. In a case-control study of
CML in Sweden, no association (p=0.91)
was found between the disease and occupa-
tional exposures to petroleum products
(95). Thus, the authors concluded that,
unlike the patients with ANLL, occupa-
tional exposures to petroleum products was
not particularly common among the
patients with CML (95). In another
case-control study of CML conducted by
investigators at the University ofLeeds and
the University of Edinburgh (89), expo-
sure histories of 122 CML cases and 241
controls were examined. This study did not
find any association between CML and
exposures to benzene or solvents (p=0.41).
The authors concluded that the study
failed to reveal any risks for solvent or
chemical exposure (89). Thus, there is no
increased CML risk associated with
chronic exposures to benzene or other aro-
matic hydrocarbons. This conclusion is
consistent with the view expressed in the
Ceil Textbook ofMedicine (19th ed.,
p. 933): "Benzene exposure increases the
risk ofacute myelogenous leukemia (AML)
but not ofCML" (90).
For ALL, only cohort K showed a
significant increase (SMR=2.60, 95% CI:
1.12-5.11). A review of the available
employment histories of the ALL cases by
the authors of the original cohort did not
shed any additional light on a possible
explanation for the excess. Moreover, it is
interesting to note that there was a signi-
ficant deficit of CLL (3 observed vs 10.04
expected) in the same cohort. Five of the
eight ALL cases in cohort K were diag-
nosed in a small county in the South, and,
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therefore, the ALL excess coupled with a
CLL deficit could have been the result of
misclassification due to local diagnostic
practice. Even if only one case had been
misclassified, the ALL SMR for cohort K
would not have been statistically significant.
No other individual cohorts showed a
significant increase ofALL. In fact, no ALL
deaths were reported in six individual
cohorts. For the U.S. and U.K. combined
cohort, the observed number of ALL
deaths was not significantly different from
the expected (34 observed versus 29.36
expected, p=0.40). Because ofthe rarity of
ALL, few population-based case-control
studies ofALL have addressed the issue of
ALL in petroleum workers. In a case-con-
trol study based on 5147 leukemia deaths
from 16 states in the United States,
Loomis and Savitz (91) reported that not a
single ALL case had worked in the petro-
leum refining industry (odds ratio = 0).
Although the number ofALL in the study
was not reported, it can be estimated that
approximately 10% ofthe total number or
500 were ALL. The finding from the
Loomis and Savitz (91) study that none of
the ALL cases worked in the petroleum
industry supported the results of the ALL
meta-analysis in the present investigation.
In a review on environmental factors of
leukemia, Brandt (92) also concluded that,
unlike ANLL, there is little evidence that
the development of ALL is related to
exposure to some chemicals.
Finally for CLL, as remarked above,
cohort K exhibited a significant deficit. On
the other hand, cohort C showed a signifi-
cant excess of CLL (SMR=2.59, 95% CI:
1.18-4.91). As discussed earlier, approxi-
mately 4 statistically significant SMRs
could be expected to occur by chance,
given that there were 76 SMRs tested at
the a =0.05 level. Indeed, there were three
statistically significant SMRs in Tables 3 to
6. For the U.S. combined cohort, the CLL
SMR was 0.79 (95% CI: 0.59-1.03),
almost significantly low at the 0.05 level.
For the U.S. and U.K. combined cohort,
the CLL meta-SMR was 0.84, indicating
that there was no increased CLL risk
among petroleum workers in the United
States or the United Kingdom. This finding
was supported by a recent case-control
study ofchronic lymphocytic leukemia and
chemical exposures conducted by epidemi-
ologists at the University ofWashington
(93). This study found that the risk ratio
for CLL associated with exposure to aro-
matic hydrocarbons (including benzene)
was 1.1. Similarly, in a case-control studies
of 342 CLL cases in the Baltimore area,
benzene was found to be unrelated to any
increased risk ofCLL (94). In the case-con-
trol study conducted by Loomis and Savitz
(91) discussed above, no significant increase
in CLL among petroleum refining workers
was found. Similarly, in the Swedish
case-control study conducted by Brandt et
al. (95) discussed earlier, no association
between exposure to petroleum products
and CLLwas detected (p=0.70).
In addition to the overall meta-analyses
based on all cohort studies of petroleum
workers in the United States and the United
Kingdom, we also conducted meta-analyses
restricted to studies ofrefinery workers only
(Table 7). The results-based refinery studies
were similar to those based on all petroleum
studies. Furthermore, we also performed
meta-analyses based on studies with at least
15 years offollow-up (Table 8). The results
remained unchanged, after stratification by
length offollow-up.
As discussed previously (30,44), data are
not available from individual studies for a
meta-analysis by level ofexposure to petro-
leum products. A few individual studies
have presented exposure-response analyses
by leukemia cell type. A review of these
analyses will shed additional light on the
interpretation of the meta-analyses in the
present investigation. For refinery workers,
in the case-control study of cohort G,
detailed analyses ofAML by benzene expo-
sure categories were carried out (85). The
controls were found to have a higher cumu-
lative benzene exposure than theAML cases.
Other cumulative measures ofbenzene expo-
sure were obtained using differentweighting
schemes, and for each ofthese measures the
controls consistently scored higher than the
cases. Thus, the AML increase reported in
the previous analysis ofcohort G could not
be attributed to benzene exposure. Further-
more, the increase was substantially reduced
and no longer statistically significant in the
latest update ofcohort G.
Among petroleum distribution workers,
drivers of tank trucks have the highest
potential for exposure to hydrocarbons
including benzene. In the U.K. distribution
study, Rushton (34) provided cell-type-
specific analysis for drivers. The AML SMR
for drivers was 1.55 (95% CI: 0.82-2.65).
Unfortunately, no analysis by exposure to
either total hydrocarbons or benzene was
carried out. Analysis by hire date indicated
that an increased leukemia risk (all cell
types) was observed in workers who started
work before 1940, but it was not clear
whether this result holds true for AML as
well. In the U.S. study ofdistribution work-
ers, no increased risk for either leukemia (all
cell-types combined) or AML was found for
drivers. Furthermore, exposure-response
analyses were carried out for both leukemia
(all cell-types combined) and AML in the
U.S. study (70,71). Analyses using logistic
regression models based on length ofexpo-
sure, cumulative exposure, and frequency of
peak exposure did not find any increased
risk or exposure-response relationship
between these exposure indices and
leukemia (all cell-types combined) or AML
(70). Thus, these detailed analyses from
individual studies supported the results of
the meta-analyses based on the combined
cohorts in the present investigation.
Conclusion
Epidemiologic data have demonstrated
that, given high enough exposure levels
over an extended period of time, benzene
can increase the risk ofAML. Furthermore,
where quantitative exposure estimates are
available, epidemiologic data have indi-
cated that the observed threshold needed
to increase the risk ofAML has been esti-
mated to be at least 200 ppm-years ofben-
zene exposure, and most likely substantially
higher based on more realistic exposure
estimates (in the range of 370-530 ppm-
years). The meta-analysis on AML in the
present investigation based on a combined
cohort of more than 208,000 U.S. and
U.K. petroleum workers has demonstrated
that these workers were not at an increased
risk of AML because benzene exposure
levels in the petroleum industry have been
substantially lower than needed to reach
the observed threshold.
Furthermore, in assessing the relation-
ship between benzene exposure and leuke-
mia, a distinction must be made with
respect to histological cell types of leu-
kemia. The meta-analyses on CML, A, and
CLL have demonstrated that there is no
increased risk for any of these cell-type-
specific leukemias among petroleum (refin-
ery, production, pipeline, and distribution)
workers in the United States or in the
United Kingdom. Meta-analyses restricted
to refinery studies or to studies with at least
15 years offollow-up yielded similar results.
The conclusion ofthe present investigation
is supported by case-control studies on cell-
type-specific leukemias conducted in the
United States, the United Kingdom, and
other countries.
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